Get the Stockscreener App
4.50
1.35%
+0.06
Helius Medical Technologies Inc stock is currently priced at $4.50, with a 24-hour trading volume of 5,124.
It has seen a +1.35% increased in the last 24 hours and a -19.35% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $4.58 pivot point. If it approaches the $4.30 support level, significant changes may occur.
Previous Close:
$4.44
Open:
$4.43
24h Volume:
5,124
Market Cap:
$3.99M
Revenue:
$792.00K
Net Income/Loss:
$-12.69M
P/E Ratio:
-0.2045
EPS:
-22
Net Cash Flow:
$-10.55M
1W Performance:
-12.54%
1M Performance:
-19.35%
6M Performance:
-38.44%
1Y Performance:
+2,336%
1D Range:
$4.42
$4.6892
52W Range:
$0.1383
$13.43
Helius Medical Technologies Inc Stock (HSDT) Company Profile
Name
Helius Medical Technologies Inc
Sector
Industry
Phone
215 944 6100
Address
642 Newtown Yardley Road, Suite 100, Newtown, PA
Helius Medical Technologies Inc Stock (HSDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-24-21 | Initiated | Noble Capital Markets | Outperform |
Helius Medical Technologies Inc Stock (HSDT) Latest News
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
GlobeNewswire Inc.
Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™
GlobeNewswire Inc.
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire Inc.
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
GlobeNewswire Inc.
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Helius Medical Technologies Inc Stock (HSDT) Financials Data
Helius Medical Technologies Inc (HSDT) Revenue 2024
HSDT reported a revenue (TTM) of $792.00 thousand for the quarter ending September 30, 2023, a +3.80% rise year-over-year.
Helius Medical Technologies Inc (HSDT) Net Income 2024
HSDT net income (TTM) was -$12.69 million for the quarter ending September 30, 2023, a +4.49% increase year-over-year.
Helius Medical Technologies Inc (HSDT) Cash Flow 2024
HSDT recorded a free cash flow (TTM) of -$10.55 million for the quarter ending September 30, 2023, a +32.61% increase year-over-year.
Helius Medical Technologies Inc (HSDT) Earnings per Share 2024
HSDT earnings per share (TTM) was -$21.49 for the quarter ending September 30, 2023, a +87.68% growth year-over-year.
About Helius Medical Technologies Inc
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
1.69%
0.48%
Cap:
|
Volume (24h):